RUTHERFORD, N.J. (AP) _ Cancer Genetics Inc. (CGIX) on Friday reported a loss of $1.7 million in its second quarter.
The Rutherford, New Jersey-based company said it had a loss of 79 cents per share. Losses, adjusted to account for discontinued operations, were 82 cents per share.
The diagnostics company posted revenue of $1.4 million in the period.
The company’s shares closed at $3. A year ago, they were trading at $3.90.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGIX at https://www.zacks.com/ap/CGIX
Please read our comment policy before commenting.